p53-dependent gene repression through p21 is mediated by recruitment of E2F4 repression complexes

被引:81
作者
Benson, E. K. [1 ]
Mungamuri, S. K. [1 ]
Attie, O. [2 ]
Kracikova, M. [1 ]
Sachidanandam, R. [2 ]
Manfredi, J. J. [1 ]
Aaronson, S. A. [1 ]
机构
[1] Mt Sinai Sch Med, Dept Oncol Sci, New York, NY 10029 USA
[2] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY USA
关键词
p53; p21; E2F4; RB; p130; transcriptional repression; ARF TUMOR-SUPPRESSOR; WILD-TYPE P53; CELL-CYCLE; TRANSCRIPTIONAL REPRESSION; NEGATIVE REGULATION; DOWN-REGULATION; POCKET PROTEIN; DIRECT BINDING; SURVIVIN GENE; TARGET GENES;
D O I
10.1038/onc.2013.378
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The p53 tumor suppressor protein is a major sensor of cellular stresses, and upon stabilization, activates or represses many genes that control cell fate decisions. While the mechanism of p53-mediated transactivation is well established, several mechanisms have been proposed for p53-mediated repression. Here, we demonstrate that the cyclin-dependent kinase inhibitor p21 is both necessary and sufficient for the downregulation of known p53-repression targets, including survivin, CDC25C, and CDC25B in response to p53 induction. These same targets are similarly repressed in response to p16 overexpression, implicating the involvement of the shared downstream retinoblastoma (RB)-E2F pathway. We further show that in response to either p53 or p21 induction, E2F4 complexes are specifically recruited onto the promoters of these p53-repression targets. Moreover, abrogation of E2F4 recruitment via the inactivation of RB pocket proteins, but not by RB loss of function alone, prevents the repression of these genes. Finally, our results indicate that E2F4 promoter occupancy is globally associated with p53-repression targets, but not with p53 activation targets, implicating E2F4 complexes as effectors of p21-dependent p53-mediated repression.
引用
收藏
页码:3959 / 3969
页数:11
相关论文
共 69 条
[1]   Wnt pathway aberrations including autocrine Wnt activation occur at high frequency in human non-small-cell lung carcinoma [J].
Akiri, G. ;
Cherian, M. M. ;
Vijayakumar, S. ;
Liu, G. ;
Bafico, A. ;
Aaronson, S. A. .
ONCOGENE, 2009, 28 (21) :2163-2172
[2]   p53-Mdm2 - the affair that never ends [J].
Alarcon-Vargas, D ;
Ronai, Z .
CARCINOGENESIS, 2002, 23 (04) :541-547
[3]   Repression of the Arf tumor suppressor by E2F3 is required for normal cell cycle kinetics [J].
Aslanian, A ;
Iaquinta, PJ ;
Verona, R ;
Lees, JA .
GENES & DEVELOPMENT, 2004, 18 (12) :1413-1422
[4]   DNA damage induced p53 downregulates Cdc20 by direct binding to its promoter causing chromatin remodeling [J].
Banerjee, Taraswi ;
Nath, Somsubhra ;
Roychoudhury, Susanta .
NUCLEIC ACIDS RESEARCH, 2009, 37 (08) :2688-2698
[5]   Role of progerin-induced telomere dysfunction in HGPS premature cellular senescence [J].
Benson, Erica K. ;
Lee, Sam W. ;
Aaronson, Stuart A. .
JOURNAL OF CELL SCIENCE, 2010, 123 (15) :2605-2612
[6]   Basal repression of BRCA1 by multiple E2Fs and pocket proteins at adjacent E2F sites [J].
Bindra, Ranjit S. ;
Glazer, Peter M. .
CANCER BIOLOGY & THERAPY, 2006, 5 (10) :1400-1407
[7]   One Function-Multiple Mechanisms: The Manifold Activities of p53 as a Transcriptional Repressor [J].
Boehlig, Levin ;
Rother, Karen .
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY, 2011,
[8]   New insights into p53 activation [J].
Brooks, Christopher L. ;
Gu, Wei .
CELL RESEARCH, 2010, 20 (06) :614-621
[9]   Requirement for p53 and p21 to sustain G2 arrest after DNA damage [J].
Bunz, F ;
Dutriaux, A ;
Lengauer, C ;
Waldman, T ;
Zhou, S ;
Brown, JP ;
Sedivy, JM ;
Kinzler, KW ;
Vogelstein, B .
SCIENCE, 1998, 282 (5393) :1497-1501
[10]   Abduction and asylum in the lives of transcription factors [J].
Burger, Anat ;
Walczak, Aleksandra M. ;
Wolynes, Peter G. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (09) :4016-4021